Epicardial Ablation is a specialized medical procedure designed to target and address cardiac arrhythmias by focusing on the outer surface of the heart, known as the epicardium. This approach becomes necessary when conventional endocardial ablation, which involves accessing the heart's inner chambers, proves inadequate for certain cases. Cardiac arrhythmias, characterized by irregular heartbeats, can significantly impact an individual's well-being and pose serious health risks. Epicardial ablation is particularly effective when arrhythmias originate in anatomical regions that are challenging to reach through traditional means. The procedure involves the careful navigation of a catheter to the epicardium, where controlled lesions are created using advanced techniques such as radiofrequency energy. This precise intervention disrupts the aberrant electrical signals responsible for the arrhythmia, showcasing effectiveness in managing complex cases. Patients undergoing epicardial ablation often experience restored normal heart rhythm, leading to an improvement in overall cardiovascular health.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States